Zydus Lifesciences shares: The follow-up audit, conducted under Good Manufacturing Practices (GMP), took place from June 9 to June 18, 2025...

Crisil Ratings reports that President Trump's order to cut US drug prices will have a limited effect on Indian pharma. India's exports, mai...

The Indian pharmaceutical sector is poised for significant growth, driven by favorable trade agreements and increasing global demand for ge...

Zydus Lifesciences on Saturday said the US health regulator has issued six observations after inspecting its Gujarat-based API manufacturin...

Sensex and Nifty hit new highs. NCLAT directs NCLT to re-hear APL Apollo Tubes insolvency plea. Reliance Jio's tech collaboration with TM F...

Indian pharmaceutical market flattened after the pandemic led to a massive upsurge in demand for drugs. The industry saw a rise in sales du...

TCS, Delta Corp, Birla Tyres, Kesoram Industries, Lasa Supergenerics, Elnet Technologies, Hathway Bhawani Cabletel and MPL Plastics are amo...

US drugmaker Gilead Sciences on Tuesday donated 450,000 vials of the Covid-19 drug remdesivir to India, even as the delayed supplies from i...

A Zydus Cadila spokesperson said, "The current spike in COVID-19 cases has led to a higher demand of Remdesivir. We are currently producing...

A state health department official said the state has more stock than that. Maharashtra is also planning to put a ban on the retail sale of...

"Under the leadership of Prime Minister Narendra Modi, the government continues to strive to improve the ease of doing business in the coun...

The presidential order issued on August 6 called for federal agencies involved in the procurement of essential medicines, medical counterme...

The company's active pharmaceutical ingredient (API) manufacturing facility located at Ankleshwar (unit 1), Gujarat has received an Establi...

Companies have rationalised field force and restructured product portfolio to up productivity.

The USFDA has banned products of Laxachem Organics, a maker of active pharmaceutical ingredients, from US markets as part of the effort to ...

Teva Pharmaceutical Industries’ $40.5-billion purchase of Allergan’s generics business may help Indian generic-drug makers acquire products

The excise duty incentives announced in this year’s budget may have been welcomed by the industry, but it has spelt doom for excise free zo...